# Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation

Study · id `cardio:ct-nct03199703` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03199703](<https://clinicaltrials.gov/study/NCT03199703>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03199703

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

## Technical summary

Registry record NCT03199703. Randomized; no masking; primary purpose treatment. Start 2017-01-17 (actual); primary completion 2019-05-17 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 135 participants (enrolled count; ClinicalTrials.gov record NCT03199703, source copy `cardio:ctgov-nct03199703-2020-12-08`, retrieved 2026-10-26)
- Started: 2017-01-17 (actual) (ClinicalTrials.gov record NCT03199703, source copy `cardio:ctgov-nct03199703-2020-12-08`, retrieved 2026-10-26)
- Primary completion: 2019-05-17 (actual) (ClinicalTrials.gov record NCT03199703, source copy `cardio:ctgov-nct03199703-2020-12-08`, retrieved 2026-10-26)
- Completion: 2020-08-01 (actual) (ClinicalTrials.gov record NCT03199703, source copy `cardio:ctgov-nct03199703-2020-12-08`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT03199703, source copy `cardio:ctgov-nct03199703-2020-12-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03199703-2020-12-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Conventional Versus RF Needle Transseptal Puncture for Cryoballoon Ablation
- Acronym: CRYO-LATS
- Condition: Atrial Fibrillation
- Intervention (Device): Baylis transseptal system group
- Intervention (Device): Standard conventional transseptal group
- Lead sponsor: Jason Andrade
- Lead sponsor class: OTHER
- Collaborator: Baylis Medical Company
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial (`cardio:pubmed-35739438`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0da27baa9f9d0f06bbf443eb941f1f0493e668db39f04762a1988d2621a0332d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
